Is the V3 loop involved in HIV binding to CD4?

被引:11
作者
Dettin, M
Ferranti, P
Scarinci, C
Picariello, G
Di Bello, C
机构
[1] Univ Padua, Dept Chem Proc Engn, I-35131 Padua, Italy
[2] CNR, Inst Food Sci & Technol, I-83100 Avellino, Italy
关键词
D O I
10.1021/bi0340696
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The entry of the human immunodeficiency virus into cells requires the interaction of the viral envelope glycoprotein gp120 with CD4 and a chemokine receptor. The gp120 binding site has been previously mapped to the Ig-CDR2-like region of CD4 first domain. A second area of this domain (Ig-CDR3-like region) is involved in gp120-CD4 interactions, but its gp120 counterpart remained so far unknown. Using a photoaffinity labeling experiment, we demonstrate that a peptide, mapping the (307-330)m region of HIV-MN-gp120 V3 loop, binds a sequence including a part of the Ig-CDR3-like region. These results may contribute to explain the complex mechanism of human immunodeficiency virus penetration, helping the development of new therapeutic agents.
引用
收藏
页码:9007 / 9012
页数:6
相关论文
共 38 条
[1]   IDENTIFICATION OF THE RESIDUES IN HUMAN CD4 CRITICAL FOR THE BINDING OF HIV [J].
ARTHOS, J ;
DEEN, KC ;
CHAIKIN, MA ;
FORNWALD, JA ;
SATHE, G ;
SATTENTAU, QJ ;
CLAPHAM, PR ;
WEISS, RA ;
MCDOUGAL, JS ;
PIETROPAOLO, C ;
AXEL, R ;
TRUNEH, A ;
MADDON, PJ ;
SWEET, RW .
CELL, 1989, 57 (03) :469-481
[2]   BINDING TO CD4 OF SYNTHETIC PEPTIDES PATTERNED ON THE PRINCIPAL NEUTRALIZING DOMAIN OF THE HIV-1 ENVELOPE PROTEIN [J].
AUTIERO, M ;
ABRESCIA, P ;
DETTIN, M ;
DIBELLO, C ;
GUARDIOLA, J .
VIROLOGY, 1991, 185 (02) :820-828
[3]   ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS) [J].
BARRESINOUSSI, F ;
CHERMANN, JC ;
REY, F ;
NUGEYRE, MT ;
CHAMARET, S ;
GRUEST, J ;
DAUGUET, C ;
AXLERBLIN, C ;
VEZINETBRUN, F ;
ROUZIOUX, C ;
ROZENBAUM, W ;
MONTAGNIER, L .
SCIENCE, 1983, 220 (4599) :868-871
[4]  
Bayley H, 1983, PHOTOGENERATED REAGE
[5]  
BERGER EA, 1997, AIDS, V11, P3
[6]   Transduction of activation signal that follows HIV-1 binding to CD4 and CD4 dimerization involves the immunoglobulin CDR3-like region in domain 1 of CD4 [J].
Briant, L ;
Signoret, N ;
Gaubin, M ;
RobertHebmann, V ;
Zhang, X ;
Murali, R ;
Greene, MI ;
PiatierTonneau, D ;
Devaux, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (31) :19441-19450
[7]   A CD4 DOMAIN IMPORTANT FOR HIV-MEDIATED SYNCYTIUM FORMATION LIES OUTSIDE THE VIRUS BINDING-SITE [J].
CAMERINI, D ;
SEED, B .
CELL, 1990, 60 (05) :747-754
[8]   ANTIBODY RAISED AGAINST SOLUBLE CD4-RGP120 COMPLEX RECOGNIZES THE CD4 MOIETY AND BLOCKS MEMBRANE-FUSION WITHOUT INHIBITING CD4-GP120 BINDING [J].
CELADA, F ;
CAMBIAGGI, C ;
MACCARI, J ;
BURASTERO, S ;
GREGORY, T ;
PATZER, E ;
PORTER, J ;
MCDANAL, C ;
MATTHEWS, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (04) :1143-1150
[9]   The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates [J].
Choe, H ;
Farzan, M ;
Sun, Y ;
Sullivan, N ;
Rollins, B ;
Ponath, PD ;
Wu, LJ ;
Mackay, CR ;
LaRosa, G ;
Newman, W ;
Gerard, N ;
Gerard, C ;
Sodroski, J .
CELL, 1996, 85 (07) :1135-1148
[10]   The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection [J].
Cocchi, F ;
DeVico, AL ;
GarzinoDemo, A ;
Cara, A ;
Gallo, RC ;
Lusso, P .
NATURE MEDICINE, 1996, 2 (11) :1244-1247